Pathology and Immunology
Trypanosomiasis and the nervous system: Pathology and immunology : Damage to the nervous system appear in both African and American trypanosomiases , but it differs appreciable in form and extent in each disease, and with particular strains and disease stages. With Trypanosoma brucei infections there is a progressive central nervous system (CNS) pathology which associate the meninges, choroid, blood-brain barrier, and immune pathological changes including perivascular infiltrations, astrocyte activation and alterations in the cytokine/mediator network. These innovation underly the altered behaviour in the late or secondary disease stages, prevalent in the chronic gambian form, indicate by hypersomnia leading, if untreated or if treatment is followed by reactive changes, to coma and death.
Related Conference of Pathology and Immunology
21th International Conference on Allergic Diseases and Clinical Immunology
13th World Congress and Exhibition on Antibiotics and Antibiotic Resistance
Pathology and Immunology Conference Speakers
Recommended Sessions
- Allergy and Therapies
- Allergy, Hypersensitivity and Asthma
- Animal & Plant-Derived Vaccines
- Autoimmune Disorders
- Cancer Immunology and Immunotherapy
- Cellular Immunology and Latest Innovations
- Child Immunization and Vaccination Viral Immunology
- Clinical Immunology: Current & Future Research
- DNA & Synthetic Conjugate Vaccines Travel & Edible Vaccines
- Genetics Immunology & Vaccinology
- Geriatric Immunizations
- Haematopoietic and Lymphoid Malignancies and Immune System Development
- Immunologic Techniques, Microbial Control and Therapeutics
- Infectious Diseases, Emerging and Re-emerging Diseases: Confronting Future Outbreaks
- Neuro Immunology
- Paediatric Vaccinations
- Pathology and Immunology
- Pediatric Immunology
- Stem Cell Immunology
- Vaccines for Immune Mediated Diseases
Related Journals
Are you interested in
- Antibiotic Prophylaxis - Antibiotics 2026 (UK)
- Antibiotic Resistance: Opportunities and Challenges - Antibiotics 2026 (UK)
- Antibiotic-resistant Bacterial infections - Antibiotics 2026 (UK)
- Antibiotics - Antibiotics 2026 (UK)
- Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- Antibiotics: In Pregnancy and Lactation - Antibiotics 2026 (UK)
- Antimicrobial Peptides - Antibiotics 2026 (UK)
- Antimicrobial Therapy - Antibiotics 2026 (UK)
- Clinical Trials of Antibiotics - Antibiotics 2026 (UK)
- Current Research in Antibiotic Resistance - Antibiotics 2026 (UK)
- Developing Alternatives to Antibiotics - Antibiotics 2026 (UK)
- Drug Discovery and Novel Delivery Technologies - Antibiotics 2026 (UK)
- Immunology & Vaccines - Antibiotics 2026 (UK)
- Infectious Diseases - Antibiotics 2026 (UK)
- Mechanisms and Evolution of Antibiotic Resistance - Antibiotics 2026 (UK)
- Micro Organisms in Recent Drug Discovery - Antibiotics 2026 (UK)
- Microorganisms Producing Antibiotics - Antibiotics 2026 (UK)
- Modern Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- New antibiotics and non-antibiotic approaches - Antibiotics 2026 (UK)
- Pharmacokinetics and Pharmacodynamics of Antimicrobial Drugs - Antibiotics 2026 (UK)
- Pharmacology & Toxicology - Antibiotics 2026 (UK)
- Prevention and Control of Antibiotic Resistance - Antibiotics 2026 (UK)
- The Next Generation Approach of Antibiotics - Antibiotics 2026 (UK)

